We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.61%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$97.6B
AUM Growth
+$13.8B
Cap. Flow
+$6.87B
Cap. Flow %
7.05%
Top 10 Hldgs %
24.85%
Holding
8,027
New
582
Increased
3,285
Reduced
3,349
Closed
442

Sector Composition

Rank Sector Weight
1 Healthcare 5.21%
2 Financials 5.16%
3 Technology 4.66%
4 Consumer Discretionary 3.61%
5 Energy 3.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXII
4901
DELISTED
GALENA BIOPHARMA INC COM
RXII
$203K ﹤0.01%
50,792
+32,216
+173% +$129K
BCRX icon
4902
CALL
BioCryst Pharmaceuticals
BCRX
$2.4B
$202K ﹤0.01%
28,800
-13,800
-32% -$87.4K
LZB icon
4903
La-Z-Boy
LZB
$1.69B
$202K ﹤0.01%
6,511
-22,645
-78% -$586K
WOR icon
4904
Worthington Enterprises
WOR
$2.86B
$202K ﹤0.01%
7,815
-25,845
-77% -$642K
WT icon
4905
WisdomTree
WT
$3.22B
$202K ﹤0.01%
11,889
-4,335
-27% -$61.7K
CATY icon
4906
Cathay General Bancorp
CATY
$4.24B
$201K ﹤0.01%
7,768
+4,299
+124% +$109K
FFC
4907
Flaherty & Crumrine Preferred and Income Securities Fund
FFC
$782M
$201K ﹤0.01%
11,847
+6,525
+123% +$115K
OPK icon
4908
Opko Health
OPK
$1.02B
$201K ﹤0.01%
25,099
-59,887
-70% -$605K
WNS
4909
DELISTED
WNS Holdings
WNS
$201K ﹤0.01%
9,576
+6,373
+199% +$132K
FGP
4910
DELISTED
Ferrellgas Partners, L.P.
FGP
$201K ﹤0.01%
9,156
+4,003
+78% +$92.4K
CJES
4911
CALL
DELISTED
C&J ENERGY SVCS LTD
CJES
$201K ﹤0.01%
8,700
+1,500
+21% +$34.3K
LAD icon
4912
PUT
Lithia Motors
LAD
$8.26B
$200K ﹤0.01%
2,900
-4,400
-60% -$295K
SPPP
4913
Sprott Physical Platinum and Palladium Trust
SPPP
$621M
$200K ﹤0.01%
25,000
VTI icon
4914
PUT
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
$200K ﹤0.01%
2,100
+1,100
+110% +$101K
XPP icon
4915
CALL
ProShares Ultra FTSE China 50 of PROSHARES TRUST
XPP
$8.93M
$200K ﹤0.01%
3,500
-2,200
-39% -$126K
TGP
4916
DELISTED
Teekay LNG Partners L.P.
TGP
$200K ﹤0.01%
+4,752
New +$195K
CCO icon
4917
Clear Channel Outdoor Holdings
CCO
$1.23B
$199K ﹤0.01%
19,766
-9,195
-32% -$85.1K
FBIO icon
4918
Fortress Biotech
FBIO
$88.7M
$199K ﹤0.01%
6,637
+5,772
+667% +$223K
VWTR
4919
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
$199K ﹤0.01%
8,643
+4,986
+136% +$117K
WHX
4920
DELISTED
WHITING USA TRUST I UNITS OF BENE INT
WHX
$199K ﹤0.01%
39,729
+29,701
+296% +$149K
UEIC icon
4921
Universal Electronics
UEIC
$60.1M
$198K ﹤0.01%
5,230
-4,824
-48% -$180K
BRO icon
4922
Brown & Brown
BRO
$23.9B
$197K ﹤0.01%
12,724
+2,510
+25% +$39.8K
VNR
4923
DELISTED
Vanguard Natural Resources, LLC
VNR
$197K ﹤0.01%
6,800
-979
-13% -$27.7K
CPK icon
4924
Chesapeake Utilities
CPK
$3.21B
$196K ﹤0.01%
4,871
+2,459
+102% +$91.7K
IPG
4925
PUT
DELISTED
Interpublic Group of Companies
IPG
$196K ﹤0.01%
11,500
-1,900
-14% -$32K

Similar funds

Barclays's Q4 2013 Portfolio in Review

As of Q4 2013, Barclays held 8,027 positions worth $97.6B, up 16% from $83.8B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Barclays deployed $6.87B of net new capital in Q4 2013, opening 582 new positions and adding to 3,285 existing holdings. Its largest new stake was LyondellBasell Industries: 1,615,904 shares worth $129M.

By sector, the portfolio is most concentrated in Healthcare at 5.2% of assets, up from 4.2% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $418M trimmed.

  • Barclays's largest Q4 2013 buy was LyondellBasell Industries: 1,615,904 shares worth $129M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2013, an estimated $3.38B increase.
  • Barclays's biggest Q4 2013 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $418M.
  • Barclays fully exited ONYX PHARMACEUTICALS INC in Q4 2013, selling an estimated $193M.
  • Barclays's ten largest holdings make up 25% of its $97.6B portfolio in Q4 2013.
  • Barclays opened 582 new positions and closed 442 in Q4 2013.
  • Barclays's portfolio value rose 16% quarter-over-quarter to $97.6B.

Based on Barclays's 13F filing for Q4 2013, filed 13 Feb 2014.